Johnson Pharmacare MD, chairman, board of directors and AGM
BSE: 532154Commercial Services & SuppliesSmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹0.39.
- Under BSE's graded surveillance, stage 0, on the list for 22 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹21 Cr3,837th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 19 Jun 2026
- 49.3
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 13 Aug 2026
- −200.6%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹14 crore of one-off items, the largest of them in the quarter to Mar 2026.
- −150.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 13 Aug 2026
- −195.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 19 Jun 2026
- 49.18
- Volume, BSEVolume. Shares traded on the last trading day.
- 6,12,963
Johnson Pharmacare board of directors
At the end of the quarter to Jun 2026, as the company filed it; changes since are in its announcements.Their trades in its shares
- ChairpersonDHEERAJ KUMAR
4 directors2 independent1 executive1 non-executive
- PARUL AGRAWALIndependent · joined Feb 2026 · 5 months as independent · 1 listed board · 1 as independent
- BABITAIndependent · joined Jan 2026 · 5 months as independent · 1 listed board · 1 as independent · 2 committee seats
- NAND KISHOR RAYNon-executive · joined Apr 2026 · 3 months as independent · 1 listed board · 1 committee seat, 1 as chair
- DHEERAJ KUMAR · ChairpersonExecutive · joined Apr 2026 · 3 months as independent · 1 listed board · 2 committee seats
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
5 directors who left
- UMESH KUMAR, left 17 Apr 2026: Others
- RAJENDER PARSAD, left 17 Apr 2026: Others
- RAMANLAL NAGJIBHAI TRIVEDI, left 6 Oct 2025: Others
- PARESHBHAI GANPATBHAI SENGAL, left 6 Oct 2025: Others
- MANISHA MANEKLAL PATEL, left 12 Sep 2025: Others
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 27 May 20264 of 4 present2 independent · 39 days in between
- 17 Apr 20264 of 4 present2 independent · 61 days in between
- 14 Feb 20264 of 4 present2 independent
Audit Committee
Chair PARUL AGRAWAL
BABITA, DHEERAJ KUMAR
- 27 May 20263 of 3 present2 independent · 101 days in between
- 14 Feb 20263 of 3 present2 independent
Nomination and remuneration committee
Chair PARUL AGRAWAL
BABITA, NAND KISHOR RAY
- 17 Apr 20263 of 3 present2 independent · 63 days in between
- 12 Feb 20263 of 3 present2 independent
Stakeholders Relationship Committee
Chair NAND KISHOR RAY
BABITA, DHEERAJ KUMAR
No meeting listed in the filing.
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Statutory auditor
Named in the results for the quarter to Mar 2026.
- VRSK & ASSOCIATESPeer-review certificate valid to Mar 2028
1 earlier auditor
- RISHI SEKHRI AND ASSOCIATES Chartered AccountantsNamed in the filing for the quarter to Mar 2025
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The board is made up as the listing rules require
- Yes
- The board has a regular chairperson
- Yes
- The company has a risk management committee
- No
- The chair is related to the managing director
- No
- The filing has a part on fines and penalties
- No
- The filing has a part on tax disputes
- No
- There was a cyber security incident in the quarter
- No
The company's own answers in its filing.